Airway management

Comparative evaluation of nebulized versus intravenous dexmedetomidine on intubating conditions during awake fiberoptic nasotracheal intubation

J Clin AnesthPublished Randomised controlled trial

Authors' conclusion

Nebulisation with dexmedetomidine results in desirable degree of sedation and better tolerance of the procedure with adequate attenuation of the haemodynamic responses to intubation.

Study context

Population
ASA I/II adults scheduled for elective ENT surgery undergoing awake fiberoptic nasotracheal intubation
Participants
46 adults
Comparison
ND vs ID
  • NDn = 23
  • IDn = 23reference
Primary endpoint
Cough score
Methodological detailsdouble-blind, All patients received midazolam 1 mg i.v. as premedication
  • Double-blind
  • All patients received midazolam 1 mg i.v. as premedication

Primary result

As reported in the abstract

Cough score, nebulized vs comparator (values as printed)

2.43 ± 0.992 vs 3.52 ± 1.082

Secondary outcomes

RSS — RSS, nebulized vs comparator (values as printed) · significantly lower in nebulized group
3.30 ± 0.926 vs 4.22 ± 1.126 · P = 0.004
Number of SAYGO boluses required — SAYGO boluses, nebulized vs comparator (values as printed) · significantly lower in nebulized group
2.74 ± 0.864 vs 3.57 ± 1.161 · P = 0.009
Post-intubation score — Post-intubation score, nebulized vs comparator (values as printed) · significantly lower in nebulized group
1.48 ± 0.593 vs 2.17 ± 0.778 · P = 0.001

Original publication

Comparative evaluation of nebulized versus intravenous dexmedetomidine on intubating conditions during awake fiberoptic nasotracheal intubation. J Clin Anesth. Published 11 April 2024. doi:10.1016/j.jclinane.2024.111461

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.